Finally, evaluation of mRNA expression of colorectal cancer specimen (TCGA project) revealed a poorer survival prognosis of patients suffering from colorectal cancer if tumor samples display low Pals1 and SMAP1 expression in contrast to tumors with either Pals1 or SMAP1 downregulation. The gene discussed is PALS1; the disease is neoplasm.